Background Spinal cord injury (SCI) is a devastating disease that causes major motor,
sensory and autonomic dysfunctions. Currently, there is a lack of effective treatment. In this …

As of now, there are no satisfactory treatments for spinal cord injury (SCI), so new
therapeutic approaches are necessary to be explored. Adipose-derived mesenchymal stem …

Spinal cord injury (SCI) may lead to severe motor and sensory dysfunction, causing high
mortality and disability rates. Adipose tissue-derived mesenchymal stem/stromal cells …

Spinal cord injury (SCI) is a highly debilitating disorder of the central nervous system that
can severely impact an affected patient's quality of life. This study aimed to examine how …

Exosomes derived from mesenchymal stem cells (MSCs) have been considered as an
alternative for cell therapy of acute spinal cord injury (ASCI). However, the underlying …

Neuronal death is the main cause of nerve function impairment after spinal cord injury (SCI).
Exosome-based therapy has become a novel strategy for tissue injury repair. We designed a …

Macrophage/microglia polarization acts as an important part in regulating inflammatory
responses in spinal cord injury (SCI). However, the regulation of inflammation of Schwann …

Acute traumatic spinal cord injury is a devastating event without effective therapeutic
approach. The feeble plasticity of spinal cord microvascular endothelial cells (SCMECs) …

Objective The therapeutic benefits of exosomes obtained from mesenchymal stem cells
(MSCs) in acute spinal cord injury (SCI) have been demonstrated in recent years, but the …

Background Macrophage in the spinal cord injury (SCI) area imparts a chronic pro-
inflammation effect that challenges the recovery of SCI. Previously, endothelial progenitor …